Molecular Diagnostics Market To Make Great Impact In Near Future by 2026

1. Global Molecular Diagnostics Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016-2026 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

2. FutureMarket Insights (FMI) is apremier provider of syndicated research reports, custom research reports, andconsulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technologyinputs,valuablegrowthinsights,aerialviewofthecompetitiveframework,andfuturemarkettrends. Weprovideresearchservicesat aglobalas wellas regionallevel;keyregionsincludeGCC, ASEAN,andBRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for ourclient. Research Capabilities Sector Coverage  Automotive and Transportation  Electronics, Semiconductor, and ICT  Retail and Consumer Products  Industrial Automation and Equipment  Customized Research  Syndicated Research  Investment Research  Social Media Research  Chemicals & Materials  Food and Beverages  Services and Utilities  Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager -Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research

3. Report Description Report Description Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified the instruments in providing accurate results. This ability of the diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The concept of personalized medicine has emerged out of molecular diagnostics. Molecular Diagnostics Market: Drivers & Restraints The factors driving molecular diagnostic market are increase in demand for care facilities, favorable regulatory policies which aims at promoting the care diagnosis, acceptance of personalized medicine, development in biomarkers, advancements in proteomics, increasing awareness of the diagnostic procedures. However rising cost of molecular diagnostics, obligation of skilled labors to handle the complexity of instruments are the factors restraining the growth of molecular diagnostics market. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb- 1262 Molecular Diagnostics Market: Segmentation Molecular diagnostic market is classified on the basis of product, technology, application, end use and geography.

4. Report Description Report Description Based on product, the global molecular diagnostic market is segmented into the following: Instruments Reagents Others (service and software) Based on technology, the global molecular diagnostic market is segmented into the following: DNA sequencing Polymerase chain reaction Isothermal Nucleic Acid Amplification Technology Transcription Mediated Amplification (TMA) In situ hybridization Sequencing Microarrays Mass spectrometry DNA sequencing Others (southern blotting, northern blotting, electrophoresis) Genetic testing Infectious disease

5. Report Description Report Description Prenatal Neurological disease Cardiovascular disease Based on end use, the global molecular diagnostic market is segmented into following: Diagnostic laboratories Hospitals Others( nursing home, blood banks, point of care) Molecular Diagnostics Market: Overview The awareness of diagnosis is giving rise to the trend of self-care management. The early diagnosis of disease or disorder helps the patient in getting better treatment and cure. Infectious disease and Oncology is estimated to be the fastest growing application owing to the increased prevalence of cancer and demand for early diagnosis. The introduction to specific biomarkers for the treatment has a positive impact over the molecular diagnosis market. However maximum use of reagents is estimated owing to their accurate results. Commonly used reagents are salts, formamide, sodium dodecyl sulfate and dextran sulphate heparin. Growing awareness about the prenatal genetic testing for early detection of chromosomal abnormalities during pregnancy has enhanced the use of molecular diagnostics. Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1262

6. Report Description Report Description Molecular Diagnostics Market: Region-wise Outlook Depending on geographic regions, the Global Molecular Diagnostics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. North America is estimated to be the largest player in molecular diagnostic market owing to the technological advancements and innovations, increase in R&D investments by large pharmaceutical and biotechnological industries and demand for early diagnosis. Asia Pacific is estimated in rising molecular diagnostic market due to increase in the prevalence of diseases such as cardiovascular diseases, infectious diseases and large population suffering from diabetes. Molecular diagnostics Market: Key Players Some of the key players identified in the molecular diagnostic market are Abbott laboratories, Becton Dickinson, Novartis, Roche Diagnostics, Johnson and Johnson, Bio-Rad Laboratories, bioMerieux, Danaher Corporation, Qiagen N.V, Siemens Healthcare, Cepheid, Hologic, Inc,. Browse Full Report@ http://www.futuremarketinsights.com/reports/molecular-diagnostics- market

7. Report Description Report Description Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified the instruments in providing accurate results. This ability of the diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The concept of personalized medicine has emerged out of molecular diagnostics. Molecular Diagnostics Market: Drivers & Restraints The factors driving molecular diagnostic market are increase in demand for care facilities, favorable regulatory policies which aims at promoting the care diagnosis, acceptance of personalized medicine, development in biomarkers, advancements in proteomics, increasing awareness of the diagnostic procedures. However rising cost of molecular diagnostics, obligation of skilled labors to handle the complexity of instruments are the factors restraining the growth of molecular diagnostics market. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb- 1262 Molecular Diagnostics Market: Segmentation Molecular diagnostic market is classified on the basis of product, technology, application, end use and geography.

8. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705